Market Overview - During the past week (July 28 to August 1), all three major A-share indices experienced declines, with the Shanghai Composite Index closing at 3559.95 points, down 0.94% for the week [2] - The Shenzhen Component Index closed at 10991.32 points, down 1.58%, while the ChiNext Index closed at 2322.63 points, down 0.74% [2] - Over 31% of stocks rose during the week, with 128 stocks increasing by over 15%, while 14 stocks fell by more than 15% [2] Top Gainers - Nanjing New Pharmaceutical (688189.SH) led the weekly gainers with a 78.01% increase, followed by Dongxin Technology (688110.SH) with a 53.68% rise [4] - Other notable gainers included Southern Road Machinery (603280.SH), Sixuan New Materials (301489.SZ), Dongjie Intelligent (300486.SZ), and Lide Man (300289.SZ), all with weekly gains exceeding 46% [4] Nanjing New Pharmaceutical - Nanjing New Pharmaceutical specializes in antiviral drugs and is currently planning to acquire a domestic pharmaceutical technology asset group, which has led to a significant stock price increase of nearly 70% over three days [5][7] - The company has faced continuous financial pressure, reporting net losses of -78.83 million yuan in 2022, -10.87 million yuan in 2023, and projected losses of -357 million yuan in 2024 [6] - The stock price surged by 17.01% and 20% on July 28 and 29, respectively, and reached a 20% limit up on July 31, closing at 17.14 yuan [7] Top Losers - Aimer Group (603511.SH) was the biggest loser, with a weekly decline of 23.19%, attributed to unmet performance targets leading to the repurchase and cancellation of restricted stock [9] - The company, which focuses on the design, production, and sales of lingerie and homewear, reported a revenue drop from 33.00 billion yuan in 2022 to 31.63 billion yuan in 2024, with a corresponding decline in net profit [10][12] - Aimer's stock experienced significant volatility, hitting a limit down on July 29 and closing at 15.97 yuan with a trading volume of 4.1 billion yuan [10]
筹划购买药品技术等资产组事项,南新制药三日涨近70%丨透视一周牛熊股